Hyundai Mobis Co. has come up with an in-house brainwave-based driver monitoring system that can reduce the risk of drowsy driving by up to one-third.
The system, dubbed M.Brain, is a wearable earpiece that continuously detects and analyzes drivers' brain activity.
The company has examined the actual effect of the technology through a pilot study on public buses in Gyeonggi Province over the past year in partnership with the Gyeonggi Research Institute.
According to the findings, drivers who used M.Brain saw their risk of careless driving during after-meal hours, when drowsy driving is most common, drop by up to 30 percent.
M.Brain helped minimize the danger of careless driving by roughly 20% on highways where drowsy driving can lead to multi-car accidents.
When sloppy driving was detected in real-time, the device helped drivers recover attention within 2.3 seconds by blasting an alarm over the speakers and vibrating the seat.
This is nearly three times faster than the 6.7 seconds it took non-M.Brain drivers to regain attention.


Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
CATL Stock Hits Record High After Q1 2025 Earnings Surge
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
Want to cut your energy bills? Here’s how five experts are doing it
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 



